Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.49059 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.38209 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 9.62474 | 97 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.42254 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.51146 | 86 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.38014 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.57481 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.5578 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.67537 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.43429 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.33202 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.32287 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.47772 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.47428 | 71 |